Paul F. Truex, Director at Milestone Pharmaceuticals Inc. (MIST), bought 81,780 shares at $5.60 ($144K) on 2022-05-31, disclosed to the SEC on 2022-06-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.12 | 8,016 | $9K | 6.2% |
| 2 | $1.54 | 22,870 | $35K | 24.5% |
| 3 | $1.54 | 45,072 | $69K | 48.3% |
| 4 | $2.66 | 822 | $2K | 1.5% |
| 5 | $5.60 | 5,000 | $28K | 19.5% |
| Total | $1.76 avg | 81,780 |
| $144K |
| 100% |
| Filing → |
| ANTH | SELL | 2012-02-17 | $118K | — | Filing → |
| ANTH | SELL | 2012-01-19 | $101K | — | Filing → |
| ANTH | SELL | 2011-12-16 | $95K | — | Filing → |